Internal Medicine, Hematology & Oncology · New York, NY
NPI
1134678451
Since 2016
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
1275 York Ave, Box 8
New York, NY, 10065
Phone (212) 639-2282
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
898 services
Medicare patients, 2024
314
Average age 76
Drug cost, 2024
$4.6M
1,553 prescriptions
Company payments, 2025
$1,263
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deaglan McHugh was code 99214 (office e&m - established), 373 times for 159 patients. In total Deaglan McHugh billed 898 services in 12 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 373 | 159 | $87.26 | $33K |
| 99213 Office E&M - Established | Office | 350 | 192 | $55.49 | $19K |
| 99215 Office E&M - Established | Office | 78 | 38 | $127.81 | $9,969 |
| 99205 Office E&M - New | Office | 48 | 48 | $164.82 | $7,912 |
| 99204 Office E&M - New | Office | 11 | 11 | $121.01 | $1,331 |
By year: 2022 $76K for 918 services; 2023 $78K for 998 services; 2024 $75K for 898 services.
Medicare prescription drug claims, 2024
In 2024, the drug Deaglan McHugh prescribed most often to Medicare patients was Prednisone, with 446 prescriptions and refills. In total Deaglan McHugh wrote 1,553 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 446 | 542 | 82 | $1,907 |
| Abiraterone Acetate Generic | 397 | 443 | 62 | $1.3M |
| Xtandi Enzalutamide | 141 | 141 | 17 | $1.7M |
| Tamsulosin Hcl Generic | 91 | 227 | 30 | $1,900 |
| Nubeqa Darolutamide | 67 | 69 | 11 | $828K |
| Oxybutynin Chloride Generic | 53 | 79 | 15 | $958 |
| Orgovyx Relugolix | 29 | 31 | Under 11 | $81K |
| Pantoprazole Sodium Generic | 29 | 57 | 13 | $304 |
| Ondansetron Hcl Generic | 28 | 28 | 20 | $297 |
| Erleada Apalutamide | 24 | 24 | Under 11 | $334K |
| Oxycodone Hcl Generic | 24 | 24 | 14 | $339 |
| Finasteride Generic | 18 | 20 | Under 11 | $92.09 |
| Dexamethasone Generic | 16 | 18 | Under 11 | $338 |
| Fondaparinux Sodium Generic | 13 | 13 | Under 11 | $5,746 |
| Amlodipine Besylate Generic | 12 | 24 | Under 11 | $152 |
Brand drugs: 284 claims; generic drugs: 1,269 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deaglan McHugh $1,263 ($1,263 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Biotech, Inc. with $1,263.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $1,263 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.